Sponsored by
PoYo.AI
MBZUAI / BiMediX2-70B
Model's Last Updated: December 16 2024
image-text-to-text
Introduction of BiMediX2-70B
Model Details of BiMediX2-70B
BiMediX2 : Bio-Medical EXpert LMM for Diverse Medical Modalities
BiMediX2-70B Model
Mohamed Bin Zayed University of Artificial Intelligence (MBZUAI), UAE
License & Citation
BiMediX2 is released under the CC-BY-NC-SA 4.0 License. For more details, please refer to the LICENSE file included in our BiMediX repository.
⚠️ Warning! This release, intended for research, is not ready for clinical or commercial use.
Users are urged to employ BiMediX2 responsibly, especially when applying its outputs in real-world medical scenarios. It is imperative to verify the model's advice with qualified healthcare professionals and not rely on it for medical diagnoses or treatment decisions. Despite the overall advancements BiMediX2 shares common challenges with other language models, including hallucinations, toxicity, and stereotypes. BiMediX2's medical diagnoses and recommendations are not infallible.
If you use BiMediX2 in your research, please cite our work as follows:
@misc{mullappilly2024bimedix2biomedicalexpertlmm,
title={BiMediX2: Bio-Medical EXpert LMM for Diverse Medical Modalities},
author={Sahal Shaji Mullappilly and Mohammed Irfan Kurpath and Sara Pieri and Saeed Yahya Alseiari and Shanavas Cholakkal and Khaled Aldahmani and Fahad Khan and Rao Anwer and Salman Khan and Timothy Baldwin and Hisham Cholakkal},
year={2024},
eprint={2412.07769},
archivePrefix={arXiv},
primaryClass={cs.CV},
url={https://arxiv.org/abs/2412.07769},
}
Runs of MBZUAI BiMediX2-70B on huggingface.co
23
Total runs
-1
24-hour runs
2
3-day runs
4
7-day runs
8
30-day runs
More Information About BiMediX2-70B huggingface.co Model
Url of BiMediX2-70B
BiMediX2-70B huggingface.co Url
Provider of BiMediX2-70B huggingface.co
Other API from MBZUAI
Total runs:
2.6K
Run Growth:
-3.1K
Growth Rate:
-117.75%
Total runs:
1.7K
Run Growth:
-385
Growth Rate:
-23.05%
Total runs:
1.2K
Run Growth:
-92
Growth Rate:
-7.44%
Total runs:
1.1K
Run Growth:
-1.4K
Growth Rate:
-126.49%
Total runs:
1.1K
Run Growth:
-1.2K
Growth Rate:
-110.15%
Total runs:
916
Run Growth:
-1.2K
Growth Rate:
-133.30%
Total runs:
824
Run Growth:
329
Growth Rate:
39.93%
Total runs:
783
Run Growth:
783
Growth Rate:
100.00%
Total runs:
461
Run Growth:
-272
Growth Rate:
-59.00%
Total runs:
377
Run Growth:
-147
Growth Rate:
-37.98%
Total runs:
373
Run Growth:
-58
Growth Rate:
-15.30%
Total runs:
270
Run Growth:
-1.2K
Growth Rate:
-440.52%
Total runs:
210
Run Growth:
135
Growth Rate:
64.29%
Total runs:
192
Run Growth:
47
Growth Rate:
24.48%
Total runs:
159
Run Growth:
-1.6K
Growth Rate:
-974.84%
Total runs:
133
Run Growth:
-6
Growth Rate:
-4.72%
Total runs:
110
Run Growth:
20
Growth Rate:
18.02%
Total runs:
57
Run Growth:
-38
Growth Rate:
-67.86%
Total runs:
35
Run Growth:
10
Growth Rate:
28.57%
Total runs:
26
Run Growth:
6
Growth Rate:
23.08%
Total runs:
23
Run Growth:
9
Growth Rate:
37.50%
Total runs:
22
Run Growth:
10
Growth Rate:
43.48%
Total runs:
21
Run Growth:
-1
Growth Rate:
-4.76%
Total runs:
21
Run Growth:
10
Growth Rate:
47.62%
Total runs:
19
Run Growth:
-22
Growth Rate:
-115.79%
Total runs:
16
Run Growth:
4
Growth Rate:
25.00%
Total runs:
16
Run Growth:
6
Growth Rate:
37.50%
Total runs:
14
Run Growth:
5
Growth Rate:
33.33%
Total runs:
12
Run Growth:
2
Growth Rate:
16.67%
Total runs:
11
Run Growth:
-20
Growth Rate:
-181.82%
Total runs:
8
Run Growth:
-2
Growth Rate:
-25.00%
Total runs:
8
Run Growth:
2
Growth Rate:
25.00%
Total runs:
8
Run Growth:
0
Growth Rate:
0.00%
Total runs:
7
Run Growth:
-2
Growth Rate:
-28.57%
Total runs:
7
Run Growth:
-4
Growth Rate:
-57.14%
Total runs:
4
Run Growth:
-3
Growth Rate:
-75.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%
Total runs:
0
Run Growth:
0
Growth Rate:
0.00%